Skip to main content
. 2016 Feb 5;38(1):58–74. doi: 10.1016/j.bjhh.2016.01.001
P – Elderly patients (>60 years) with AML undergoing consolidation treatment
I – Cytarabine with anthracycline
C – Cytarabine without anthracycline
O – Complete remission rate, overall survival, and disease-free survival